Author Archives: admin

SALT LAKE CITY, UT (Business Wire) – Seek Labs, a biotechnology company boldly seeking a healthier world through AI-powered discovery, programmable therapeutics, and point-of-care diagnostics, today announced the publication of a peer-reviewed paper in Viruses (MDPI), revealing the first successful use of a CRISPR-based therapeutic to treat African Swine Fever Virus (ASFV) in pigs. The […]

This first-of-its-kind infant care collaboration for Owlet enables clinicians to access Owlet’s data through Locus Health’s platform, enhancing visibility, improving care continuity, and supporting families after hospital discharge. LEHI, Utah–(BUSINESS WIRE)– Owlet, Inc. (“Owlet” or the “Company”) (NYSE: OWLT), the pioneer of smart infant monitoring, today announces a partnership with Locus Health, a leader in […]

As part of Governor Spencer Cox’s Australia Trade Mission from October 19–25, BioUtah led a focused Life Sciences Track highlighting Utah’s growing global leadership in biotechnology, medtech, diagnostics, and health innovation. The delegation met with prominent Australian partners, investors, and regulators to explore opportunities for collaboration and market expansion. Companies participating in the trade mission […]

    Salt Lake City, Utah – October 21, 2025 Salt Lake City-based biotech firm Seek Labs announced today that it has expanded its Global Disease Atlas™ to include several of the world’s deadliest hemorrhagic fever viruses (HFVs) — namely, Ebola virus, Marburg virus, Lassa virus, Hantavirus, Crimean‑Congo hemorrhagic fever virus (CCHFV), and Rift Valley fever virus (RVFV). In July, the company announced that it […]

LEHI, Utah, Oct. 23, 2025 /PRNewswire/ — Halia Therapeutics, Inc., a clinical-stage biopharmaceutical company pioneering therapies that target the root causes of inflammation-driven diseases, today announced that the U.S. Food and Drug Administration (FDA) has granted Orphan Drug Designation (ODD) to its investigational medicine ofirnoflast (HT-6184) for the treatment of Myelodysplastic Syndromes (MDS) — a group […]

SALT LAKE CITY, October 21, 2025— ARUP Laboratories today announced the publication of an article in the Journal of Clinical Microbiology describing the company’s validation of a deep convolutional neural network (CNN) to detect parasites in concentrated wet mounts of stool.  For decades, detection of gastrointestinal parasites has relied on traditional microscopy, which is a […]

SALT LAKE CITY, Utah, Oct. 20, 2025 (GLOBE NEWSWIRE) — SINTX Technologies, Inc. (NASDAQ: SINT) (“SINTX” or the “Company”), a leader in advanced ceramics specializing in biomedical applications of silicon nitride (Si₃N₄), today announced U.S. Food and Drug Administration (FDA) 510(k) clearance for the SINAPTIC® Foot & Ankle Osteotomy Wedge System, enabling SINTX’s commercial entry […]

The State of Innovation Conference, hosted by The Nucleus Institute, brought together entrepreneurs, investors, policymakers, and researchers to explore pathways, partnerships, and funding strategies for breakthrough technologies. The day began with keynote speaker Jerry Hollister, who spoke on federal innovation funding trends, followed by a panel highlighting Utah companies that had successfully leveraged SBIR/STTR awards, […]

CivicaScript®, LLC, a nonprofit company dedicated to bringing low-cost generic medicines to U.S. patients, today announced the availability of generic dalfampridine extended release tablets. Dalfampridine is a potassium channel blocker indicated to improve walking in certain adult patients with multiple sclerosis (MS). Specific information about the use of dalfampridine can be found here. CivicaScript will […]